KMA and Co.
  • Why
  • Who
  • What
  • Where
  • Case Studies
  • Reports
  • Blog
Select Page
Digital Therapeutics is Primed for a Return to the Roaring 20’s

Digital Therapeutics is Primed for a Return to the Roaring 20’s

by Cassie Arnold | Apr 20, 2021 | Deal making, Digital Health, Digital Therapeutic, Investment, Modern Work, Venture capital

For 2021, our data partner DealForma is providing venture investment data in addition to the data they have been sharing on M&A deals.  As we all know, VC investment was on a roll in 2020. Silicon Valley Bank has reported that venture investment in...
In a Time of COVID, Dealmakers Take a Shine to Diagnostics and Vaccines

In a Time of COVID, Dealmakers Take a Shine to Diagnostics and Vaccines

by Cassie Arnold | Feb 9, 2021 | Biotech Finance, COVID, Deal making, Investment

If you had an inkling that more money went to vaccine and diagnostic companies in 2020, you were right.  Diagnostics and vaccines have long been the red-headed stepchildren of life sciences investments. Detecting and treating life threatening diseases is the...

Newsletter

Subscribe for notifications of new posts, and occasional other news from KMA & Company.




Recent Posts

  • Opportunity Costs
  • Let Me Repeat That
  • Numbers Tell Stories
  • Five Bits of Advice on MarCom Tactics
  • TL;DR*, Less is More, Short and Sweet

Categories

  • 21st Century Culture
  • Advertising
  • Biotech Finance
  • Branding
  • Communications
  • COVID
  • Deal making
  • Digital Health
  • Digital Therapeutic
  • Digital Therapeutics
  • Gender at Work
  • Investment
  • Modern Work
  • Persuasion
  • Sales
  • Venture capital
  • X
  • RSS
Copyright © 2025 KMA & Company